ArticleFrontiers in pediatrics2023

A phase 1, first-in-child, multicenter study to evaluate the safety and efficacy of the oncolytic herpes virus talimogene laherparepvec in pediatric patients with advanced solid tumors.

Lucas Moreno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.